First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Trial StartPositive

AI Analysis

Summary

Ananda Pharma Limited has dosed the first patient in a clinical trial for its cannabidiol medicine to treat chemotherapy induced peripheral neuropathy. The company is a UK-based biopharmaceutical developer of regulatory-approved cannabidiol medicines for chronic conditions.

Clinical Trial Data

Outcome Details

First patient dosed in CIPN clinical trial

Importance:4/10

Sentiment:

0.30

clinical trialcannabidiolchemotherapy induced peripheral neuropathyCIPNfirst patient dosed

Related Companies

$TRAX

Read the original article

Published by PR Newswire Pharma on July 17, 2026 8:41 AM

Read Original